Alto Neuroscience, Stock Analysis
ANRO Stock | 4.41 0.13 3.04% |
Alto Neuroscience, is undervalued with Real Value of 11.17 and Target Price of 31.5. The main objective of Alto Neuroscience, stock analysis is to determine its intrinsic value, which is an estimate of what Alto Neuroscience, is worth, separate from its market price. There are two main types of Alto Neuroscience,'s stock analysis: fundamental analysis and technical analysis.
The Alto Neuroscience, stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Alto Neuroscience, is usually not traded on Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day. Alto Stock trading window is adjusted to America/New York timezone.
Alto |
Alto Stock Analysis Notes
About 13.0% of the company shares are held by company insiders. The book value of Alto Neuroscience, was presently reported as 6.67. The company recorded a loss per share of 1.85. Alto Neuroscience, had not issued any dividends in recent years. For more info on Alto Neuroscience, please contact B BCom at 650 200 0412 or go to https://www.altoneuroscience.com.Alto Neuroscience, Investment Alerts
Alto Neuroscience, generated a negative expected return over the last 90 days | |
Alto Neuroscience, has high historical volatility and very poor performance | |
Net Loss for the year was (36.3 M) with profit before overhead, payroll, taxes, and interest of 0. | |
Alto Neuroscience, generates negative cash flow from operations | |
Alto Neuroscience, has a frail financial position based on the latest SEC disclosures | |
Over 75.0% of the company shares are held by institutions such as insurance companies | |
Latest headline from accesswire.com: The Schall Law Firm Invites Stockholder Contributions To An Inquiry Into Alto Neuroscience, Inc. For Securities Fraud |
Alto Largest EPS Surprises
Earnings surprises can significantly impact Alto Neuroscience,'s stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2024-08-14 | 2024-06-30 | -0.67 | -0.6 | 0.07 | 10 | ||
2024-05-14 | 2024-03-31 | -0.46 | -0.76 | -0.3 | 65 | ||
2024-03-21 | 2023-12-31 | -1.67 | -7.77 | -6.1 | 365 |
Alto Neuroscience, Environmental, Social, and Governance (ESG) Scores
Alto Neuroscience,'s ESG score is a quantitative measure that evaluates Alto Neuroscience,'s performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Alto Neuroscience,'s operations that may have significant financial implications and affect Alto Neuroscience,'s stock price as well as guide investors towards more socially responsible investments.
Alto Neuroscience, Thematic Classifications
In addition to having Alto Neuroscience, stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
ComputersUSA Equities from Computers industry as classified by Fama & French | ||
BiotechBiotechnology and pharmaceuticals production and services | ||
Health ManagementHealthcare providers, hospitals |
Alto Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 367.18 M.Alto Profitablity
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.42) | (0.44) | |
Return On Capital Employed | (0.47) | (0.49) | |
Return On Assets | (0.42) | (0.44) | |
Return On Equity | 0.51 | 0.72 |
Technical Drivers
As of the 1st of December, Alto Neuroscience, shows the Mean Deviation of 4.73, standard deviation of 9.85, and Risk Adjusted Performance of (0.04). Alto Neuroscience, technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Alto Neuroscience, Price Movement Analysis
The output start index for this execution was nine with a total number of output elements of fifty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Alto Neuroscience, middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Alto Neuroscience,. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Alto Neuroscience, Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Alto Neuroscience, insiders, such as employees or executives, is commonly permitted as long as it does not rely on Alto Neuroscience,'s material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Alto Neuroscience, insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Savitz Adam over two months ago Acquisition by Savitz Adam of 10681 shares of Alto Neuroscience, at 12.53 subject to Rule 16b-3 | ||
Savitz Adam over three months ago Acquisition by Savitz Adam of 2931 shares of Alto Neuroscience, at 13.22 subject to Rule 16b-3 | ||
Alpha Wave Global Lp over six months ago Conversion by Alpha Wave Global Lp of 1962995 shares of ANRO | ||
Chen Po Yu Jeff over six months ago Conversion by Chen Po Yu Jeff of 259 shares of ANRO | ||
Chen Po Yu Jeff over six months ago Acquisition by Chen Po Yu Jeff of 30574 shares of ANRO subject to Rule 16b-3 | ||
Alkeon Capital Management Llc over six months ago ANRO exotic insider transaction detected |
Alto Neuroscience, Predictive Daily Indicators
Alto Neuroscience, intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Alto Neuroscience, stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Alto Neuroscience, Corporate Filings
13A | 14th of November 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
13A | 12th of November 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
13A | 8th of November 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
8K | 22nd of October 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 21st of October 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
8K | 13th of August 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
8K | 29th of July 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 11th of July 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
Alto Neuroscience, Forecast Models
Alto Neuroscience,'s time-series forecasting models are one of many Alto Neuroscience,'s stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Alto Neuroscience,'s historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Alto Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Alto Neuroscience, prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Alto shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Alto Neuroscience,. By using and applying Alto Stock analysis, traders can create a robust methodology for identifying Alto entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | (39.37) | (41.34) | |
Operating Profit Margin | (51.67) | (54.25) | |
Net Loss | (39.37) | (41.34) | |
Gross Profit Margin | 0.28 | 0.25 |
Current Alto Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Alto analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Alto analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
31.5 | Strong Buy | 6 | Odds |
Most Alto analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Alto stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Alto Neuroscience,, talking to its executives and customers, or listening to Alto conference calls.
Alto Stock Analysis Indicators
Alto Neuroscience, stock analysis indicators help investors evaluate how Alto Neuroscience, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Alto Neuroscience, shares will generate the highest return on investment. By understating and applying Alto Neuroscience, stock analysis, traders can identify Alto Neuroscience, position entry and exit signals to maximize returns.
Begin Period Cash Flow | 48.3 M | |
Long Term Debt | 9.9 M | |
Common Stock Shares Outstanding | 26.9 M | |
Total Stockholder Equity | -71.7 M | |
Property Plant And Equipment Net | 1.1 M | |
Cash And Short Term Investments | 82.5 M | |
Cash | 82.5 M | |
Accounts Payable | 1.1 M | |
Net Debt | -72.6 M | |
50 Day M A | 12.174 | |
Total Current Liabilities | 5.6 M | |
Other Operating Expenses | 37.8 M | |
Non Current Assets Total | 1.2 M | |
Non Currrent Assets Other | 131 K | |
Stock Based Compensation | 2.9 M |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alto Neuroscience,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Alto Stock, please use our How to Invest in Alto Neuroscience, guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alto Neuroscience,. If investors know Alto will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alto Neuroscience, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.85) |
The market value of Alto Neuroscience, is measured differently than its book value, which is the value of Alto that is recorded on the company's balance sheet. Investors also form their own opinion of Alto Neuroscience,'s value that differs from its market value or its book value, called intrinsic value, which is Alto Neuroscience,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alto Neuroscience,'s market value can be influenced by many factors that don't directly affect Alto Neuroscience,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alto Neuroscience,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Alto Neuroscience, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alto Neuroscience,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.